{
    "2019-10-01": [
        [
            {
                "time": "2019-10-21",
                "original_text": "Johnson & Johnson Reaches Settlement Agreement with Two Ohio Counties Ahead of Upcoming Opioid Trial",
                "features": {
                    "keywords": [
                        "settlement",
                        "opiod",
                        "trial"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-10-22",
                "original_text": "Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know",
                "features": {
                    "keywords": [
                        "gains",
                        "market dips"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-23",
                "original_text": "Opioid makers, distributors face shaky future as legal woes mount",
                "features": {
                    "keywords": [
                        "opioid",
                        "distributors",
                        "legal woes"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-10-24",
                "original_text": "Here is How Hedge Fundsâ€™ Most Popular Stock Performed in Q3",
                "features": {
                    "keywords": [
                        "hedge funds",
                        "popular stock",
                        "Q3 performance"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "Geron's Imetelstat Gets Fast Track Status for Myelofibrosis",
                "features": {
                    "keywords": [
                        "imetelstat",
                        "fast track",
                        "myelofibrosis"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-10-26",
                "original_text": "AstraZeneca/Merck's Lynparza Positive in Prostate Cancer Study",
                "features": {
                    "keywords": [
                        "lynparza",
                        "prostate cancer",
                        "study positive"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-10-27",
                "original_text": "Mallinckrodt Up on Settlement Agreement With Ohio Counties",
                "features": {
                    "keywords": [
                        "mallinckrodt",
                        "settlement",
                        "up"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-10-28",
                "original_text": "Drugmakers look to use Purdue Pharma's bankruptcy to settle U.S. opioid suits: WSJ",
                "features": {
                    "keywords": [
                        "drugmakers",
                        "purdue pharma",
                        "bankruptcy",
                        "opioid suits"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-10-29",
                "original_text": "UPDATE 1-Drugmakers look to use Purdue Pharma's bankruptcy to settle U.S. opioid suits -WSJ",
                "features": {
                    "keywords": [
                        "drugmakers",
                        "purdue pharma",
                        "bankruptcy",
                        "opioid suits"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}